Repair Biotechnologies
Operator of a preclinical biotechnology company intended to develop drugs for cholesterol and aging-related diseases. The company's cholesterol-degrading platform (CDP) technology is aimed at reversin...
Valuation
$74.4M
Latest known
Share Price
N/A
Total Raised
$22.9M
Last Round
N/A